Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;16(1):2531595.
doi: 10.1080/20008066.2025.2531595. Epub 2025 Aug 12.

Eye movement desensitisation and reprocessing as a potential treatment for substance use disorders: study protocol

Affiliations

Eye movement desensitisation and reprocessing as a potential treatment for substance use disorders: study protocol

Daniel Folch Sanchez et al. Eur J Psychotraumatol. 2025 Dec.

Abstract

ABSTRACTBackground: Prior exposure to traumatic events significantly increases the risk of developing substance use disorders (SUD), while having SUD, in turn, elevates the likelihood of encountering additional traumatic events. Despite this relationship, the consequences of trauma frequently go undetected and untreated in this population. The trauma-focused intervention eye movement desensitisation and reprocessing (EMDR), a first-line treatment for post-traumatic stress disorder (PTSD), has shown promising therapeutic potential in SUD patients. However, its underlying neurobiological mechanisms remain unclear. This study aims to investigate the efficacy of EMDR in SUD patients with comorbid psychological trauma. Additionally, potential mechanisms of action of the intervention will be explored. The primary hypothesis is that integrating EMDR into standard SUD treatment will enhance substance use prognosis.Methods: Sixty-four patients with SUD and trauma symptomatology will be randomised into two groups. One group will receive EMDR trauma-focused intervention in 6-8 sessions alongside treatment as usual (TAU) (n = 32), while the control group will receive TAU only (n = 32). The primary outcome will be the time to relapse, assessed at baseline, immediately after treatment, and at 1- and 3-months follow-up. Additional measures include post-traumatic, anxiety, depressive symptoms and biological markers (hair/salivary cortisol levels, eye blink conditioning, and resting-state fMRI). Survival analysis and linear mixed models will be used to assess treatment effects. The trial is registered on ClinicalTrials.gov (NCT05488691).Discussion: This study addresses a critical gap in scientific literature and clinical practice by evaluating the efficacy of EMDR, in patients with SUD and comorbid trauma symptoms, through a combination of clinical and biological markers. The findings could lead to integration of personalised, trauma-focused interventions into public health services for patients with SUD.

Antecedentes: La exposición previa a eventos traumáticos aumenta significativamente el riesgo de desarrollar trastornos por uso de sustancias (TUS), mientras que tener un TUS, a su vez, eleva la probabilidad de experimentar eventos traumáticos adicionales. A pesar de esta relación, las consecuencias del trauma suelen pasar desapercibidas y no se tratan en esta población. La intervención centrada en el trauma denominada desensibilización y reprocesamiento por movimientos oculares (EMDR), un tratamiento de primera línea para el trastorno de estrés postraumático (TEPT), ha mostrado un potencial terapéutico prometedor en pacientes con TUS. Sin embargo, los mecanismos neurobiológicos subyacentes de su acción aún no están claros. Este estudio tiene como objetivo investigar la eficacia del EMDR en pacientes con TUS y trauma psicológico comórbido. Además, se explorarán los posibles mecanismos de acción de la intervención. Se espera que la integración de la intervención EMDR al tratamiento estándar del TUS mejorará el pronóstico clínico de esta enfermedad.

Métodos: Sesenta y cuatro pacientes con TUS y sintomatología de trauma serán asignados aleatoriamente a dos grupos. Un grupo recibirá la intervención centrada en el trauma EMDR en 6–8 sesiones junto con el tratamiento habitual (TAU) (n = 32), mientras que el grupo control recibirá únicamente TAU (n = 32). El resultado principal será el tiempo hasta la recaída, evaluado al inicio, inmediatamente después del tratamiento, y en los seguimientos a 1 y 3 meses. También se evaluarán los cambios en los síntomas postraumáticos, de ansiedad o depresión y se analizarán posibles biomarcadores de respuesta (cortisol en cabello y saliva, condicionamiento del parpadeo y conectividad cerebral en estado de reposo mediante fMRI). Se realizará un análisis de supervivencia y modelos lineales mixtos para evaluar los efectos del tratamiento. El ensayo está registrado en ClinicalTrials.gov (NCT05488691).

Discusión: Este estudio aborda una brecha crítica en la literatura científica y en la práctica clínica al evaluar la eficacia de EMDR en pacientes con TUS, mediante una combinación de marcadores clínicos y biológicos. Los hallazgos podrían conducir a la integración de intervenciones personalizadas y centradas en el trauma en los servicios de salud pública que atienden a personas con TUS.

Keywords: Desensibilización y reprocesamiento por movimientos oculares; Eye movement desensitisation and reprocessing; addiction; adicción; cerebellum; cerebelo; ensayo aleatorizado controlado; intervención centrada en el trauma; randomised controlled trial; substance use disorder; trastorno por uso de sustancias; trauma-focused intervention.

Plain language summary

This study evaluates the effectiveness of Eye Movement Desensitisation and Reprocessing (EMDR) as a treatment for substance use disorders in individuals with co-occurring trauma, addressing a critical gap in addiction care.By combining clinical outcomes such as relapse rates with biological markers like cortisol levels and brain activity, this research explores the underlying neurobiological mechanisms of EMDR.Findings could support the integration of trauma-focused therapies into public health services, offering tailored interventions to improve recovery outcomes for patients with substance use disorders.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Similar articles

References

    1. Adamaszek, M., D'Agata, F., Ferrucci, R., Habas, C., Keulen, S., Kirkby, K. C., Leggio, M., Mariën, P., Molinari, M., Moulton, E., Orsi, L., Van Overwalle, F., Papadelis, C., Priori, A., Sacchetti, B., Schutter, D. J., Styliadis, C., & Verhoeven, J. (2017). Consensus paper: Cerebellum and emotion. The Cerebellum, 16(2), 552–576. 10.1007/s12311-016-0815-8 - DOI - PubMed
    1. Alcohol and Drug Foundation . (n.d.). Relapse. Retrieved from https://adf.org.au/reducing-risk/relapse/.
    1. Allen, M. T., Handy, J. D., Miller, D. P., & Servatius, R. J. (2019). Avoidance learning and classical eyeblink conditioning as model systems to explore a learning diathesis model of PTSD. Neuroscience & Biobehavioral Reviews, 100, 370–386. 10.1016/j.neubiorev.2019.03.003 - DOI - PubMed
    1. Bernstein, D. P., & Fink, L. (1997). Childhood trauma questionnaire: A retrospective self-report (CTQ). Pearson.
    1. Bernstein, E. M., & Putnam, F. W. (1986). Development, reliability, and validity of a dissociation scale. The Journal of Nervous and Mental Disease, 174, 727–735. 10.1097/00005053-198612000-00004 - DOI - PubMed

Publication types

Associated data